Special Considerations of Anastomotic Leak in Patients with Rectal Cancer
- PMID: 34853565
- PMCID: PMC8610639
- DOI: 10.1055/s-0041-1735275
Special Considerations of Anastomotic Leak in Patients with Rectal Cancer
Abstract
Anastomotic leak in patients with rectal cancer has the potential to cause worse oncologic outcomes in addition to major morbidity and mortality risk of this dreaded complication. Anatomic location of the rectal cancer determines the ability to perform a restorative operation and the height of the anastomosis in relation to the anal canal. Clinical staging dictates the need for neoadjuvant treatment (such as chemotherapy and radiation) which may also contribute to anastomotic leak risk. In addition to oncologic outcomes, anastomotic leak can impact bowel function, the need for permanent stoma, and long-term quality of life. This study will discuss special considerations for anastomotic leak prevention and clinical implications of this complication in patients with rectal cancer.
Keywords: anastomotic leak; function; oncologic outcome; rectal cancer.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest None declared.
References
-
- Konishi T, Watanabe T, Kishimoto J, Nagawa H. Risk factors for anastomotic leakage after surgery for colorectal cancer: results of prospective surveillance. J Am Coll Surg. 2006;202(03):439–444. - PubMed
-
- Bellows C F, Webber L S, Albo D, Awad S, Berger D H. Early predictors of anastomotic leaks after colectomy. Tech Coloproctol. 2009;13(01):41–47. - PubMed
-
- Alves A, Panis Y, Trancart D, Regimbeau J M, Pocard M, Valleur P. Factors associated with clinically significant anastomotic leakage after large bowel resection: multivariate analysis of 707 patients. World J Surg. 2002;26(04):499–502. - PubMed
-
- Dutch ColoRectal Audit group . Sparreboom C L, van Groningen J T, Lingsma H F. Different risk factors for early and late colorectal anastomotic leakage in a nationwide audit. Dis Colon Rectum. 2018;61(11):1258–1266. - PubMed
-
- Terzi C, Bingul M, Arslan N C. Randomized controlled trial of 8 weeks' vs 12 weeks' interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer. Colorectal Dis. 2020;22(03):279–288. - PubMed
